US BANCORP \DE\ - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 27 filers reported holding BIOCEPT INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$198
-35.9%
5830.0%0.00%
Q4 2022$3095830.0%0.00%
Q3 2022$05830.0%0.00%
Q2 2022$0
-100.0%
5830.0%0.00%
Q1 2022$1,000
-50.0%
5830.0%0.00%
Q4 2021$2,0000.0%5830.0%0.00%
Q3 2021$2,0000.0%5830.0%0.00%
Q2 2021$2,000
-33.3%
5830.0%0.00%
Q1 2021$3,000
+50.0%
5830.0%0.00%
Q4 2020$2,000
-33.3%
583
-13.6%
0.00%
Q3 2020$3,0006750.00%
Other shareholders
BIOCEPT INC shareholders Q1 2023
NameSharesValueWeighting ↓
GLOBEFLEX CAPITAL L P 233,578$215,0000.04%
SABBY MANAGEMENT, LLC 30,502$28,0000.04%
Taylor & Morgan Wealth Management, LLC 26,000$24,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,436$101,0000.00%
CASTLE WEALTH MANAGEMENT LLC 1,350$1,0000.00%
VANGUARD GROUP INC 617,610$569,0000.00%
Focused Wealth Management, Inc 1$00.00%
UBS Group AG 12,356$11,0000.00%
OSAIC HOLDINGS, INC. 7,000$6,0000.00%
FMR LLC 1$00.00%
View complete list of BIOCEPT INC shareholders